Trials / Terminated
TerminatedNCT00528294
Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trials examines the feasibility of GRID-therapy combined with biologically imaging based IMRT (BG-IMRT). Within this trial, the strict toxicity parameters of primary treatment of head and neck tumors are used. The GRID and BG-IMRT technique might be possible to reduce the total radiation dose 2 to 3 times.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | GRID radiotherapy | GRID-radiotherapy followed by biological imaging guided IMRT |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2007-09-12
- Last updated
- 2022-12-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00528294. Inclusion in this directory is not an endorsement.